Vita Coco (COCO) CMO sells 50K shares after major option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vita Coco Company, Inc. Chief Marketing Officer Jane Prior reported a mix of option exercises, tax withholdings, and sales of common stock. On March 5, 2026, she exercised stock options to acquire a total of 50,000 shares of common stock at an exercise price of $10.178 per share in multiple transactions.
On the same date, she disposed of 1,458 and 705 shares of common stock at $55.175 per share to satisfy tax withholding obligations tied to restricted stock unit vesting; this withholding was mandated by the company and was not a discretionary transaction. She also sold 34,159, 15,741, and 100 shares of common stock in open-market transactions at weighted average prices of $52.73, $53.32, and $54.08 per share, respectively, under a Rule 10b5-1 trading plan.
Following these transactions, she directly owned 127,399 shares of common stock. Separately, on February 20, 2026, performance conditions were satisfied for a stock option covering 14,025 shares, causing that option to vest, and she holds several other non-qualified stock options with specified time-based vesting schedules.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 50,000 shares ($2,645,922)
Net Sell
17 txns
Insider
Prior Jane
Role
Chief Marketing Officer
Sold
50,000 shs ($2.65M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 3,675 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (Right to Buy) | 23,750 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (Right to Buy) | 22,575 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,458 | $55.175 | $80K |
| Tax Withholding | Common Stock | 705 | $55.175 | $39K |
| Exercise | Common Stock | 3,675 | $10.178 | $37K |
| Exercise | Common Stock | 23,750 | $10.178 | $242K |
| Exercise | Common Stock | 22,575 | $10.178 | $230K |
| Sale | Common Stock | 34,159 | $52.73 | $1.80M |
| Sale | Common Stock | 15,741 | $53.32 | $839K |
| Sale | Common Stock | 100 | $54.08 | $5K |
| Grant/Award | Non-Qualified Stock Option (Right to Buy) | 14,025 | $16.91 | $237K |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 128,104 shares (Direct)
Footnotes (1)
- The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.07 to $53.06, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.07 to $53.84, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock options vest in four annual equal installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
FAQ
What did Vita Coco (COCO) CMO Jane Prior report in this Form 4?
She reported exercising stock options for 50,000 Vita Coco common shares, tax-related share withholdings, and open-market sales. The filing details option exercise prices, sale prices, a Rule 10b5-1 trading plan, and her remaining direct ownership after these insider transactions.
What performance-based stock option activity did Vita Coco (COCO) disclose for Jane Prior?
A stock option covering 14,025 Vita Coco shares became vested on February 20, 2026, after specified performance conditions were timely satisfied. This non-qualified stock option grant is eligible to vest based on performance targets and is now vested as to those 14,025 shares.
At what price did Jane Prior exercise Vita Coco (COCO) stock options?
On March 5, 2026, Jane Prior exercised non-qualified stock options into common stock at an exercise price of $10.178 per share. These exercises converted option positions into 50,000 Vita Coco common shares before subsequent tax withholdings and open-market sales reported in the filing.